Is Infertility on the Rise? What the Data Actually Shows

Yes, but the rise is partly real biology and partly better counting, with delayed parenthood, environmental exposures, and sharper diagnostic tools all pushing the numbers upward. To put it plainly, roughly one in six adults worldwide now report difficulty conceiving, yet that figure blends confirmed medical infertility with self-reported trouble and shifting definitions that didn’t exist decades ago.

Below you’ll find what separates genuine biological change from inflated reporting, which causes carry the strongest evidence, and which practical steps actually protect your reproductive options at any age.

Defining Infertility and Why the Definition Shapes Every Statistic

Doctors diagnose infertility after 12 months of regular unprotected intercourse for women under 35, or after six months for women over 35. A single miscarriage doesn’t count, and neither does a temporary delay. Sterility, by contrast, means a permanent, irreversible inability to conceive, which is far rarer and usually requires medical intervention rather than just patience.

Over the past 50 years, diagnostic criteria have widened, fertility tracking has gone mainstream, and the medical specialty itself has grown into a multibillion-dollar industry. Each shift pushes the apparent prevalence upward without necessarily meaning more bodies are biologically incapable of conceiving today than in 1985. The Centers for Disease Control and Prevention (CDC) tracks infertility through both clinic visits and population surveys, and those two pipelines tell slightly different stories depending on who walks into a clinic.

The clinical threshold and the gray zone before it

The one-year benchmark isn’t arbitrary. About 85% of couples in their twenties and early thirties conceive within 12 months of trying, so failing to conceive in that window signals something worth investigating. For women over 35, the six-month cutoff reflects the steeper age-related decline in egg quantity and quality.

Before that threshold, lots of people experience subfertility, meaning longer-than-average time to conceive without a clear medical block. Subfertility sits in the gray zone between normal variation and diagnosable disease, and it’s often where lifestyle, timing, and environmental factors matter most.

How self-reported data inflates the numbers

Population surveys ask whether you’ve ever had trouble conceiving, and the answers lump together brief delays, secondary infertility after a first child, and people who tried for only a few months before giving up. That survey data, which the CDC and others rely on, paints a much wider swath than clinic-confirmed diagnoses.

Clinic records capture people who sought evaluation and met medical criteria. Between self-reported difficulty and confirmed medical infertility lies a gap large enough to explain much of the apparent surge. A woman who tried for four months in her late thirties before conceiving naturally will show up as “infertile” in some surveys but not in clinical registries.

That definitional inconsistency is exactly why distinguishing genuine reproductive decline from improved detection comes first.

Separating Real Biological Trends From Better Counting

More clinic visits don’t necessarily mean more infertile people exist, because the pool of people trying to conceive has expanded, the willingness to seek help has grown, and the tools to detect problems have sharpened. Historically, infertility was hidden behind silence, shame, and a lack of effective treatment, so underreporting was the norm. Improved surveillance by the World Health Organization (WHO) and CDC now captures cases that previous generations simply never documented.

Delayed childbearing confounds nearly every dataset on age-related fertility decline. The average age of first-time mothers in the United States has climbed from about 21 in 1970 to roughly 27 today, pushing more pregnancies into the steeper part of the fertility curve. When more people try to conceive at 35 than at 25, more will hit the one-year threshold, even if underlying biology hasn’t changed.

What the sperm count research actually shows

A widely cited 2017 meta-analysis found that sperm concentration in men from Western countries dropped roughly 50% between 1973 and 2011, with no sign of the decline slowing. The study drew criticism for mixing studies of different quality and for limited geographic diversity, but follow-up analyses have generally supported the trajectory.

What remains contested is whether lower sperm counts translate directly into more infertility at the population level. Sperm concentration can fall a long way before it crosses the threshold most clinicians consider problematic for natural conception. Still, the direction of the trend, combined with evidence of declining testosterone and rising testicular cancer rates in some regions, points to something real affecting male reproductive health.

The gap between perceived and actual trends

Headlines often conflate two distinct questions: whether more people are experiencing infertility, and whether more people are being diagnosed, treated, or counted. The honest answer is that both are happening, but at different rates and for different reasons.

Social media, celebrity disclosure, and the destigmatization of fertility treatment have lowered the threshold for seeking help. Insurance coverage expansions in some states and countries have made assisted reproductive technology (ART) accessible to people who previously couldn’t afford it. These shifts inflate treatment numbers without necessarily reflecting a biological epidemic.

The Causes Driving Any Genuine Increase

Age at first pregnancy remains the single largest modifiable factor for women, because egg quantity and quality both decline sharply after the mid-thirties. This isn’t speculation; it’s well-established reproductive biology backed by decades of donor-insemination studies and IVF outcome data. When more people delay parenthood into their late thirties and forties, more will encounter age-related difficulty conceiving.

Male factor infertility now contributes to roughly half of all couples who struggle to conceive, a figure that has held steady across multiple large studies. The recognition that men contribute so substantially is itself a relatively recent shift in clinical thinking, which partly explains why rising male infertility statistics appear in some datasets.

Lifestyle and medical factors with the strongest evidence

Several factors have measurable effects on fertility outcomes across populations:

• ▸Obesity disrupts ovulation in women and reduces sperm quality in men, with effects that often reverse with weight loss.
• ▸Smoking accelerates egg loss, damages sperm DNA, and roughly doubles the time to conception for both sexes.
• ▸Excessive heat exposure, including frequent hot tub use and laptop-on-lap heat, can transiently suppress sperm production.
• ▸Anabolic steroid use shuts down the body’s own hormone production, often irreversibly.
• ▸Polycystic ovary syndrome (PCOS) affects roughly 8–13% of reproductive-age women and is the leading cause of ovulatory infertility.
• ▸Endometriosis, which is being diagnosed more often thanks to better imaging, impairs fertility in about 30–50% of women who have it.

Each of these can shift a borderline case into diagnosable infertility without changing the underlying biology of the species.

Yet these diagnostic shifts stack on top of actual physiological drivers that warrant separate scrutiny.

Environmental Exposures Worth Taking Seriously and Ones to Ignore

PFAS (per- and polyfluoroalkyl substances, the “forever chemicals” found in nonstick coatings, waterproof fabrics, and some food packaging), certain phthalates, and some pesticides have measurable reproductive effects in human studies. High exposure has been linked to reduced sperm quality, altered hormone levels, and longer time to pregnancy. The evidence is strongest for occupational exposures, such as agricultural workers with heavy pesticide contact and firefighters exposed to PFAS in firefighting foam.

Heat, ionizing radiation, and certain industrial chemicals, including solvents and heavy metals, clearly harm sperm production. These are well-documented occupational hazards, not speculative risks. The challenge is separating meaningful exposure from the background levels most people encounter in daily life.

The biomarker-versus-risk gap

Modern testing can detect trace levels of dozens of compounds in blood, urine, and follicular fluid, but detection isn’t the same as clinical risk. A measurable biomarker level doesn’t automatically translate into reduced fertility for the individual.

This gap is where much of the public confusion lives. Studies reporting “exposure associated with lower sperm count” typically compare high-exposure groups to low-exposure groups and find statistical differences at the population level. For a specific person trying to conceive, the practical question is whether reducing a given exposure will meaningfully change their odds, and the answer for most everyday exposures is: probably not enough to matter.

Practical steps without avoidance paralysis

Reducing exposure to substances with strong evidence and clear sources makes sense. Choosing stainless steel or glass for hot food storage over certain plastics, avoiding smoking and heavy drinking, and minimizing occupational chemical contact are concrete, evidence-supported choices.

The American Society for Reproductive Medicine (ASRM) and similar professional bodies do not recommend routine detoxification protocols or extreme avoidance measures for people trying to conceive. Obsessive avoidance of every potential endocrine disruptor offers diminishing returns and real psychological costs.

What Individuals Can Actually Do to Protect Fertility

Evidence-based lifestyle changes do affect conception timelines, sometimes by months. Maintaining a body mass index in the healthy range (roughly 18.5–24.9), avoiding tobacco and excessive alcohol, and timing intercourse around ovulation all have measurable effects. For men, avoiding prolonged heat exposure to the testes and limiting anabolic steroids preserve sperm production that might otherwise take months to recover.

Fertility preservation through egg or sperm freezing benefits people who genuinely anticipate delayed parenthood, especially those facing medical treatments that threaten fertility, such as chemotherapy. For healthy people in their twenties or early thirties, the cost-benefit calculation is less clear, since most will conceive naturally when ready.

When to see a specialist instead of waiting out the year

Standard advice says wait a year before seeking help, but several situations warrant earlier evaluation:

• ▸Age over 35: see a specialist after six months of trying rather than a full year.
• ▸Irregular or absent periods: cycles longer than 35 days or shorter than 21 days can signal ovulatory problems.
• ▸Known reproductive conditions: PCOS, endometriosis, or a history of testicular issues warrant prompt evaluation.
• ▸Previous cancer treatment: chemotherapy or pelvic radiation can affect fertility long after treatment ends.
• ▸Recurrent miscarriage: two or more losses warrants workup for underlying causes.
• ▸Known male factor concerns: prior testicular injury, undescended testes, or vasectomy reversal should prompt early urology referral.

Resolve, a patient advocacy organization, offers directories of specialists and support resources for people navigating these decisions. The Society for Assisted Reproductive Technology (SART) publishes clinic-specific IVF success rates, which can help if treatment becomes necessary.

Even with sound personal choices, outcomes still hinge on who can reach a clinic and who cannot.

Where Disparities and Access Shape the Bigger Picture

Socioeconomic status affects both infertility risk and treatment availability in compounding ways. People with lower incomes are more likely to experience fertility-affecting conditions like obesity, diabetes, and untreated STIs, and simultaneously less likely to have insurance coverage for evaluation or treatment. A diagnosis without the means to act on it is functionally different from no diagnosis at all.

Racial and geographic gaps in diagnosis and treatment outcomes are well documented. Black women in the United States are more likely to experience infertility but less likely to receive IVF, and when they do, their success rates are lower on average. Similar patterns show up in the United Kingdom through data tracked by the Human Fertilisation and Embryology Authority (HFEA).

Why global rates vary so sharply

Infertility rates differ substantially between high-income and low-income regions, partly because of different underlying risk factors, including higher rates of untreated pelvic infections and less access to family planning in some regions, and partly because of different definitions, diagnostic capacity, and reporting systems.

The WHO estimates that the lifetime prevalence of infertility is similar across regions, around 17.5% globally, but the burden of disease, meaning the consequences for those affected, varies enormously. A couple in a country with no ART access faces a very different reality than one with comprehensive coverage.

What equitable fertility care would require

Closing the gap requires addressing both medical access and the upstream social determinants of reproductive health. Insurance mandates, expanded public funding for ART, and better integration of fertility care into primary care would all help.

Policy changes matter, but individual action within your own circumstances still adds up. Knowing the red flags, seeking timely evaluation, and advocating for yourself in clinical settings are steps you can take regardless of the system around you.

The Bottom Line

The honest answer is that more people are being diagnosed and treated for infertility than ever before, partly because more people are seeking help, partly because biology has shifted due to later childbearing and environmental factors, and partly because surveillance has improved. The apocalyptic framing of a “fertility crisis” overstates the case, but so does dismissal.

Age, lifestyle, and exposures you can influence, combined with knowing when to seek help, remain the most powerful tools for protecting your own reproductive options.

FAQ